drug launches

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts
Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts
Fierce Pharma
Sanofi
Regeneron
drug launches
Dupixent
eczema
Flag link:
New GlaxoSmithKline CEO wants fewer, bigger new drug launches
New GlaxoSmithKline CEO wants fewer, bigger new drug launches
Yahoo/Reuters
GSK
Pharma CEOs
Emma Walmsley
drug launches
Flag link:
Biogen touts stronger-than-expected rollout for Spinraza
Biogen touts stronger-than-expected rollout for Spinraza
BioPharma Dive
Biogen
Spinraza
drug launches
SMA
spinal muscular atrophy
Flag link:
Improving outcomes start before drug launchImproving outcomes start before drug launch
Improving outcomes start before drug launchImproving outcomes start before drug launch
BioPharma Dive
clinical outcomes
drug launches
Flag link:
Chasing a big payday, new drugmakers slightly favor solo launches: Report
Chasing a big payday, new drugmakers slightly favor solo launches: Report
Fierce Pharma
drug launches
Flag link:
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Fierce Pharma
PTC Therapeutics
Emflaza
drug launches
drug pricing
Duchenne Muscular Dystrophy
Flag link:
Pfizer wins TRO against ex-marketing manager accused of stealing launch plans
Pfizer wins TRO against ex-marketing manager accused of stealing launch plans
Fierce Pharma
Pfizer
restraining order
drug launches
marketing
Flag link:
Synergy preps for Trulance launch with competitive pricing, experienced GI reps
Synergy preps for Trulance launch with competitive pricing, experienced GI reps
Fierce Pharma
Synergy Pharmaceuticals
drug launches
Trulance
drug reps
Flag link:
Amgen's Repatha wins in outcomes trial, but is the score high enough?
Amgen's Repatha wins in outcomes trial, but is the score high enough?
Fierce Pharma
Amgen
Repatha
drug launches
Flag link:
This Was, Unquestionably, the Most Disappointing Drug Launch of 2016
This Was, Unquestionably, the Most Disappointing Drug Launch of 2016
Motley Fool
drug launches
Merck
Zepatier
hepatitis C
Flag link:
Biotech Stocks: What to Watch in 2017
Biotech Stocks: What to Watch in 2017
Motley Fool
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
Flag link:
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Gilead Sciences
Biogen
JNJ
drug launches
AbbVie
Sovaldi
Imbruvica
Tecfidera
Flag link:
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
Flag link:
MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect
MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect
Seeking Alpha
MannKind
Afrezza
diabetes
drug launches
Flag link:
Reimbursement rather than Brexit more likely to impact how drugmakers order global launches
Reimbursement rather than Brexit more likely to impact how drugmakers order global launches
Medical Marketing and Media
drug launches
global launches
Brexit
reimbursement
Flag link:
MannKind turns to digital, social media to spread the word on Afrezza's relaunch
MannKind turns to digital, social media to spread the word on Afrezza's relaunch
Fierce Pharma
MannKind
Afrezza
diabetes
social media
drug launches
Flag link:
Allergan's Product Launches: Setting The Table So It Can Run It
Allergan's Product Launches: Setting The Table So It Can Run It
Seeking Alpha
Allergan
drug launches
Flag link:
Shire launches new treatment for hereditary bleeding disorder
Shire launches new treatment for hereditary bleeding disorder
BioPharma Dive
Shire
drug launches
Vonvendi
von Willebrand disease
Flag link:
Allergan's Vraylar launch a success, despite trial failure
Allergan's Vraylar launch a success, despite trial failure
BioPharma Dive
Allergan
Vraylar
drug launches
clinical trials
antipsychotics
Geodon Richter
Flag link:
Sanofi's Dengvaxia launch rocked by turmoil in Latin America
Sanofi's Dengvaxia launch rocked by turmoil in Latin America
Fierce Pharma
Sanofi
dengue
Dengvaxia
Latin America
drug launches
Flag link: